PMC:7172841 / 299-555 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":181,"end":191},"obj":"Body_part"},{"id":"T2","span":{"begin":236,"end":245},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma63261"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62852"}],"text":"RF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T5","span":{"begin":7,"end":15},"obj":"Disease"},{"id":"T6","span":{"begin":49,"end":67},"obj":"Disease"},{"id":"T7","span":{"begin":103,"end":111},"obj":"Disease"},{"id":"T8","span":{"begin":181,"end":211},"obj":"Disease"},{"id":"T9","span":{"begin":213,"end":216},"obj":"Disease"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005046"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"}],"text":"RF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":29,"end":30},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T2","span":{"begin":192,"end":202},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T3","span":{"begin":230,"end":235},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"RF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":246,"end":253},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"}],"text":"RF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D "}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":80,"end":96},"obj":"http://purl.obolibrary.org/obo/GO_0006955"},{"id":"T3","span":{"begin":181,"end":202},"obj":"http://purl.obolibrary.org/obo/GO_0042116"}],"text":"RF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D "}

{"project":"LitCovid-sentences","denotations":[{"id":"T6","span":{"begin":69,"end":141},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"RF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D "}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T5","span":{"begin":7,"end":15},"obj":"SP_7"},{"id":"T6","span":{"begin":49,"end":55},"obj":"UBERON:0002405"},{"id":"T7","span":{"begin":80,"end":86},"obj":"UBERON:0002405;GO:0006955"},{"id":"T8","span":{"begin":87,"end":96},"obj":"GO:0006955"},{"id":"T9","span":{"begin":103,"end":111},"obj":"SP_7"},{"id":"T10","span":{"begin":181,"end":191},"obj":"CL:0000235;GO:0042116"},{"id":"T11","span":{"begin":192,"end":202},"obj":"GO:0042116"},{"id":"T12","span":{"begin":230,"end":235},"obj":"SP_6;NCBITaxon:9606"},{"id":"T13","span":{"begin":236,"end":245},"obj":"CL:0000738"},{"id":"T14","span":{"begin":246,"end":253},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T59726","span":{"begin":7,"end":15},"obj":"SP_7"},{"id":"T67700","span":{"begin":49,"end":55},"obj":"UBERON:0002405"},{"id":"T7839","span":{"begin":80,"end":86},"obj":"UBERON:0002405;GO:0006955"},{"id":"T23482","span":{"begin":87,"end":96},"obj":"GO:0006955"},{"id":"T94326","span":{"begin":103,"end":111},"obj":"SP_7"},{"id":"T55692","span":{"begin":181,"end":191},"obj":"CL:0000235;GO:0042116"},{"id":"T76896","span":{"begin":192,"end":202},"obj":"GO:0042116"},{"id":"T56154","span":{"begin":230,"end":235},"obj":"SP_6;NCBITaxon:9606"},{"id":"T45303","span":{"begin":236,"end":245},"obj":"CL:0000738"},{"id":"T92944","span":{"begin":246,"end":253},"obj":"CHEBI:59132;CHEBI:59132"}],"text":"RF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D "}

{"project":"LitCovid-PubTator","denotations":[{"id":"44","span":{"begin":112,"end":120},"obj":"Species"},{"id":"45","span":{"begin":146,"end":154},"obj":"Species"},{"id":"50","span":{"begin":230,"end":235},"obj":"Species"},{"id":"56","span":{"begin":7,"end":15},"obj":"Disease"},{"id":"57","span":{"begin":49,"end":67},"obj":"Disease"},{"id":"58","span":{"begin":103,"end":111},"obj":"Disease"},{"id":"59","span":{"begin":137,"end":140},"obj":"Disease"},{"id":"60","span":{"begin":160,"end":163},"obj":"Disease"},{"id":"61","span":{"begin":181,"end":211},"obj":"Disease"}],"attributes":[{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"Tax:9606"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"Tax:9606"},{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"Tax:9606"},{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"MESH:C000657245"},{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"MESH:D007154"},{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"MESH:C000657245"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"MESH:D055501"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"RF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D "}